These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 9863398

  • 1. [Modern aspects of antiemetic therapy].
    Aleksandrović J, Dagović A, Jeremić B.
    Srp Arh Celok Lek; 1998; 126(7-8):295-303. PubMed ID: 9863398
    [Abstract] [Full Text] [Related]

  • 2. 5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?
    Aapro M, Blower P.
    Cancer; 2005 Jul 01; 104(1):1-18. PubMed ID: 15929119
    [Abstract] [Full Text] [Related]

  • 3. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.
    Mahesh R, Perumal RV, Pandi PV.
    Pharmazie; 2005 Feb 01; 60(2):83-96. PubMed ID: 15739895
    [Abstract] [Full Text] [Related]

  • 4. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J, Trnený M, Procházka B, Klener P.
    Neoplasma; 2000 Feb 01; 47(5):319-22. PubMed ID: 11130251
    [Abstract] [Full Text] [Related]

  • 5. Optimising antiemetic therapy: what are the problems and how can they be overcome?
    Aapro M.
    Curr Med Res Opin; 2005 Jun 01; 21(6):885-97. PubMed ID: 15969889
    [Abstract] [Full Text] [Related]

  • 6. 5-HT3-receptor antagonists in the control of delayed-onset emesis.
    Gridelli C.
    Anticancer Res; 2003 Jun 01; 23(3C):2773-82. PubMed ID: 12926112
    [Abstract] [Full Text] [Related]

  • 7. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
    Tomek R, Vrdoljak E, Vrbanec D, Nemet D, Matković V, Plestina S, Gugić D, Dintinjana RD, Bolanca A, Samarzija M, Petković M.
    Lijec Vjesn; 2009 Jun 01; 131(3-4):49-53. PubMed ID: 19514248
    [Abstract] [Full Text] [Related]

  • 8. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J.
    Expert Opin Drug Saf; 2004 May 01; 3(3):231-48. PubMed ID: 15155151
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Chiou TJ, Tzeng WF, Wang WS, Yen CC, Fan FS, Liu JH, Chen PM.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct 01; 63(10):729-36. PubMed ID: 11076429
    [Abstract] [Full Text] [Related]

  • 10. Pathogenesis-based treatment of chemotherapy-induced nausea and vomiting--two new agents.
    Navari RM.
    J Support Oncol; 2003 Oct 01; 1(2):89-103. PubMed ID: 15352652
    [Abstract] [Full Text] [Related]

  • 11. Comparative activity of antiemetic drugs.
    Jordan K, Schmoll HJ, Aapro MS.
    Crit Rev Oncol Hematol; 2007 Feb 01; 61(2):162-75. PubMed ID: 17208005
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Aksoylar S, Akman SA, Ozgenç F, Kansoy S.
    Pediatr Hematol Oncol; 2001 Sep 01; 18(6):397-406. PubMed ID: 11554235
    [Abstract] [Full Text] [Related]

  • 14. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M, Chaudhary L, Awan FT, Khan JK, Kojouri K, Ozer H, Tfayli A.
    J Oncol Pharm Pract; 2007 Jun 01; 13(2):69-75. PubMed ID: 17873106
    [Abstract] [Full Text] [Related]

  • 15. Granisetron: an update on its clinical use in the management of nausea and vomiting.
    Aapro M.
    Oncologist; 2004 Jun 01; 9(6):673-86. PubMed ID: 15561811
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of drug-induced nausea and vomiting].
    Herrstedt J, Dombernowsky P.
    Ugeskr Laeger; 1994 Jan 24; 156(4):453-60. PubMed ID: 8140660
    [Abstract] [Full Text] [Related]

  • 17. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
    Goodman M.
    Oncol Nurs Forum; 1997 Aug 24; 24(7 Suppl):20-32. PubMed ID: 9282378
    [Abstract] [Full Text] [Related]

  • 18. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.
    Slatkin NE.
    J Support Oncol; 2007 May 24; 5(5 Suppl 3):1-9. PubMed ID: 17566383
    [Abstract] [Full Text] [Related]

  • 19. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB.
    Clin Adv Hematol Oncol; 2004 May 24; 2(5):284-9. PubMed ID: 16163194
    [Abstract] [Full Text] [Related]

  • 20. [Nausea and vomiting].
    Fujii M.
    Nihon Rinsho; 2003 Jun 24; 61(6):954-8. PubMed ID: 12806942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.